47 results
8-K
EX-4.1
RGEN
Repligen Corp.
15 Dec 23
Entry into a Material Definitive Agreement
4:33pm
purpose hereunder.
Section 17.04. Governing Law; Jurisdiction. THIS INDENTURE AND EACH NOTE, AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER … effect as though fully set forth at this place.
This Note, and any claim, controversy or dispute arising under or related to this Note, shall
8-K
EX-10.1
RGEN
Repligen Corp.
12 Sep 23
Repligen Appoints Jason K. Garland As Chief Financial Officer
9:20am
in a lawsuit or other proceeding, if such filing is made under seal.
6. Arbitration of Disputes. Any controversy or claim arising out of or relating … or the Company may be a party with regard to any such controversy or claim, such controversy or claim shall be submitted to arbitration subject to such other
8-K
EX-10.2
idda3e sxr9
1 Jun 22
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
5:25pm
DEFR14A
zelycokjp 87bw1b
5 May 21
Revised proxy
4:16pm
8-K
EX-1.1
3597t8ync6
8 Dec 20
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
4:05pm
8-K
EX-4.1
583srqs1ul0stctjo
22 Jul 19
Entry into a Material Definitive Agreement
5:09pm
8-K
EX-4.2
skjl8o5yqwm s5h
22 Jul 19
Entry into a Material Definitive Agreement
5:09pm
8-K
EX-1.1
hxpoi 5bliz12pjexxd
18 Jul 19
Repligen Corporation Announces Proposed Public Offerings of $100 million of Common Stock and $250 million of Convertible Senior Notes
4:02pm
8-K
EX-1.2
ff593ne50uc2vg
18 Jul 19
Repligen Corporation Announces Proposed Public Offerings of $100 million of Common Stock and $250 million of Convertible Senior Notes
4:02pm
424B5
4gaf28
17 Jul 19
Prospectus supplement for primary offering
5:13pm
424B5
rja 61gzj
15 Jul 19
Prospectus supplement for primary offering
4:11pm
8-K
EX-10.2
mqux8lk
19 Jun 19
Departure of Directors or Certain Officers
4:37pm
8-K
EX-1.1
r3amd 6y9hqr13nqt5
1 May 19
Repligen Corporation Announces Proposed Public Offering
4:11pm